Prakash Gaba of prakashgaba.com told CNBC-TV18, "Orchid Pharma is a stock that is weak basically one should just sell."Orchid Pharma ended at Rs 29.50, down Rs 1.90, or 6.05 percent on the BSE.The share touched its 52-week high Rs 67.50 and 52-week low Rs 27.35 on 31 December, 2015 and 09 November, 2016, respectively.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
